ZORA.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2931, doi. 10.1093/eurheartj/ehy429
- By:
- Publication type:
- Article
Works matching IS 0195668X AND DT 2018 AND VI 39 AND IP 32
Results: 16
1
2
Uninterrupted apixaban for atrial fibrillation ablation is a reasonable alternative, but what is the significance of silent cerebral infarctions?
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2956, doi. 10.1093/eurheartj/ehy274
- By:
- Publication type:
- Article
3
Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2987, doi. 10.1093/eurheartj/ehx739
- By:
- Publication type:
- Article
4
Stroke prevention in atrial fibrillation: re-defining ‘real-world data’ within the broader data universe.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2932, doi. 10.1093/eurheartj/ehy236
- By:
- Publication type:
- Article
5
A rare cause of pericardial effusion due to intracardiac cement embolism.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 3001, doi. 10.1093/eurheartj/ehy208
- By:
- Publication type:
- Article
6
The RACE-3 is on: double-locking sinus rhythm by upstream and downstream therapy.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2997, doi. 10.1093/eurheartj/ehy018
- By:
- Publication type:
- Article
7
Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention?
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2984, doi. 10.1093/eurheartj/ehy487
- By:
- Publication type:
- Article
8
Initiating anticoagulation with the intention of cardioverting: does drug choice matter?
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2972, doi. 10.1093/eurheartj/ehy303
- By:
- Publication type:
- Article
9
The German Cardiac Society.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2923, doi. 10.1093/eurheartj/ehy427
- By:
- Publication type:
- Article
10
From Bench to Bedside.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2922, doi. 10.1093/eurheartj/ehy426
- Publication type:
- Article
11
From basic science to high performance medicine.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2919, doi. 10.1093/eurheartj/ehy425
- By:
- Publication type:
- Article
12
Building a Bridge between Physicians and Patients.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2927, doi. 10.1093/eurheartj/ehy428
- By:
- Publication type:
- Article
13
Atrial fibrillation and stroke: anticoagulation in trials and real-world settings.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2915, doi. 10.1093/eurheartj/ehy570
- By:
- Publication type:
- Article
14
Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2942, doi. 10.1093/eurheartj/ehy176
- By:
- Publication type:
- Article
15
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2959, doi. 10.1093/eurheartj/ehy148
- By:
- Publication type:
- Article
16
A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation.
- Published in:
- European Heart Journal, 2018, v. 39, n. 32, p. 2975, doi. 10.1093/eurheartj/ehy411
- By:
- Publication type:
- Article